Stargardt Disease

Fill out the online form on our Patient Registry page to learn more about how you can enroll. Click here to download a printable version of this article/fact sheet: PDF/Word. The Patient…

Watch our Facebook Session from January 25, where FBC’s Research and Education Team, Dr. Mary Sunderland and Dr. Chad Andrews, discussed four vision research and treatment trends to watch for in 2018!…

With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…

Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…

In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia,…

In medicine, innovative treatments don’t emerge out of thin air. They are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye…